Clinical Trial Update: Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for FS-1502 in patients with HER2-expressed advanced solid tumors and breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FS-1502

Snippet

Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Conditions: Solid Tumor, Breast Cancer | Phase 1 | Status: COMPLETED